Obesity as a risk factor for development and poor prognosis of breast cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 10, 2006, Pages 1160-1166

  Carmichael, A R ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

Body mass index; Body weight; Breast neoplasm; Obesity; Prognosis

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; HORMONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB;

BODY BUILD; BODY FAT; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURGERY; CONFIDENCE INTERVAL; ESTROGEN ACTIVITY; HORMONE ACTION; HUMAN; MORBIDITY; MORTALITY; NUTRITION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE; WAIST HIP RATIO; WEIGHT GAIN;

ANTINEOPLASTIC AGENTS; BODY MASS INDEX; BODY WEIGHT; BREAST NEOPLASMS; EARLY DIAGNOSIS; EXERCISE; FEMALE; HORMONES; HUMANS; NUTRITIONAL STATUS; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 33748755434     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01021.x     Document Type: Review

References (90)

1. Hu FB. Overweight and obesity in women: health risks and consequences. J Womens Health (Larchmt) 2003;12:163-72.
2. La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, et al. Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer 1997;75:441-4.
3. Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 2002;13:325-32.
4. Lahmann PH, Lissner L, Berglund G. Breast cancer risk in overweight postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004;13:1414.
5. Lahmann PH, Lissner L, Gullberg B, Olsson H, Berglund G. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study. Int J Cancer 2003;103:246-52.
6. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
7. Tehard B, Lahmann PH, Riboli E, Clavel-Chapelon F. Anthropometry, breast cancer and menopausal status: use of repeated measurements over 10 years of follow-up-results of the French E3N women's cohort study. Int J Cancer 2004;111:264-9.
8. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-51.
9. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
10. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993;15:110-32.
11. Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol 1996;143:985-95.
12. Swanson CA, Coates RJ, Schoenberg JB, Malone KE, Gammon MD, Stanford JL, et al. Body size and breast cancer risk among women under age 45 years. Am J Epidemiol 1996;143:698-706.
13. Tretli S. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 1989;44:23-30.
14. Tretli S, Haldorsen T, Ottestad L. The effect of pre-morbid height and weight on the survival of breast cancer patients. Br J Cancer 1990;62:299-303.
15. Tornberg SA, Carstensen JM. Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. Br J Cancer 1994;69:358-61.
16. de Waard F. Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 1975;35:3351-6.
17. LeMarchand L, Kolonel LN, Nomura AM. Relationship of ethnicity and other prognostic factors to breast cancer survival patterns in Hawaii. J Natl Cancer Inst 1984;73:1259-65.
18. London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE. Prospective study of relative weight, height, and risk of breast cancer. JAMA 1989;262:2853-8.
19. Vatten LJ, Kvinnsland S. Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int J Cancer 1990;45:440-4.
20. Li CI, Stanford JL, Daling JR. Anthropometric variables in relation to risk of breast cancer in middle-aged women. Int J Epidemiol 2000;29:208-13.
21. Lahmann PH, Schulz M, Hoffmann K, Boeing H, Tjonneland A, Olsen A, et al. Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer 2005;93:582-9.
22. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.
23. Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 2002;44:127-38.
24. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43.
25. Ryu SY, Kim CB, Nam CM, Park JK, Kim KS, Park J, et al. Is body mass index the prognostic factor in breast cancer?: a meta-analysis. J Korean Med Sci 2001;16:610-14.
26. Enger SM, Greif JM, Polikoff J, Press M. Body weight correlates with mortality in early-stage breast cancer. Arch Surg 2004;139:954-8.
27. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001;92:720-9.
28. Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 1992;116:26-32.
29. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004;15:875-84.
30. Galanis DJ, Kolonel LN, Lee J, Le Marchand L. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 1998;9:217-24.
31. Jain M, Miller AB. Pre-morbid body size and the prognosis of women with breast cancer. Int J Cancer 1994;59:363-8.
32. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-8.
33. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 1990;16:205-14.
34. Chang S, Alderfer JR, Asmar L, Buzdar AU. Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 2000;64:157-63.
35. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
36. McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003;21:1961-6.
37. Pujol P, Galtier-Dereure F, Bringer J. Obesity and breast cancer risk. Hum Reprod 1997;12(Suppl 1):116-25.
38. Secreto G, Zumoff B. Abnormal production of androgens in women with breast cancer. Anticancer Res 1994;14:2113-17.
39. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer 2003;45:1-16.
40. Stoll BA. Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated? Breast Cancer Res Treat 1996;38:239-46.
41. Bruning PF. Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability. J Steroid Biochem 1987;27:487-92.
42. Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, et al. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2005;14:2881-8.
43. Tannenbaum A. Relationship of body weight to cancer incidence. Arch Pathol 1940;30:509-17.
44. Verreault R, Brisson J, Deschenes L, Naud F, Meyer F, Belanger L. Dietary fat in relation to prognostic indicators in breast cancer. J Natl Cancer Inst 1988;80:819-25.
45. Zollinger TW, Phillips RL, Kuzma JW. Breast cancer survival rates among Seventh-day Adventists and non-Seventh-day Adventists. Am J Epidemiol 1984;119:503-9.
46. Kesteloot H, Sasaki S, Verbeke G, Joossens JV. Cancer mortality and age: relationship with dietary fat. Nutr Cancer 1994;22:85-98.
47. Schrijvers CT, Mackenbach JP, Lutz JM, Quinn MJ, Coleman MP. Deprivation and survival from breast cancer. Br J Cancer 1995;72:738-43.
48. Carnon AG, Ssemwogerere A, Lamont DW, Hole DJ, Mallon EA, George WD, et al. Relation between socioeconomic deprivation and pathological prognostic factors in women with breast cancer. BMJ 1994;309:1054-7.
49. Reeves MJ, Newcomb PA, Remington PL, Marcus PM, MacKenzie WR. Body mass and breast cancer. Relationship between method of detection and stage of disease. Cancer 1996;77:301-7.
50. Torgerson D. Risk factors for breast cancer. Socioeconomic differences might be explained by body mass. BMJ 1994;309:1662.
51. Stoll BA. Obesity, social class and Western diet: a link to breast cancer prognosis. Eur J Cancer 1996;32A:1293-5.
52. Haybittle J, Houghton J, Baum M. Social class and weight as prognostic factors in early breast cancer. Br J Cancer 1997;75:729-33.
53. Karjalainen S, Pukkala E. Social class as a prognostic factor in breast cancer survival. Cancer 1990;66:819-26.
54. Macleod U, Ross S, Gillis C, McConnachie A, Twelves C, Watt GC. Socio-economic deprivation and stage of disease at presentation in women with breast cancer. Ann Oncol 2000;11:105-7.
55. Taylor A, Cheng KK. Social deprivation and breast cancer. J Public Health Med 2003;25:228-33.
56. Antman K, Abraido-Lanza AF, Blum D, Brownfield E, Cicatelli B, Debor MD, et al. Reducing disparities in breast cancer survival: a Columbia University and Avon Breast Cancer Research and Care Network Symposium. Breast Cancer Res Treat 2002;75:269-80.
57. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-86.
58. Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, et al. Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 2004;36:1484-91.
59. Borugian MJ, Sheps SB, Kim-Sing C, Olivotto IA, Van Patten C, Dunn BP, et al. Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 2003;158:963-8.
60. Sellers TA, Davis J, Cerhan JR, Vierkant RA, Olson JE, Pankratz VS, et al. Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 2002;155:225-33.
61. Borugian MJ, Sheps SB, Kim-Sing C, Van Patten C, Potter JD, Dunn B, et al. Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? Cancer Epidemiol Biomarkers Prev 2004;13:1163-72.
62. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer 2002;98:279-83.
63. McNee RK, Mason BH, Neave LM, Kay RG. Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand. Breast Cancer Res Treat 1987;9:145-50.
64. Maehle BO, Tretli S, Skjaerven R, Thorsen T. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesterone receptor status. Breast Cancer Res Treat 2001;68:159-69.
65. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer 1995;76:275-83.
66. Verreault R, Brisson J, Deschenes L, Naud F. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 1989;129:260-8.
67. Ingram DM, Huang HY, Catchpole BN, Roberts A. Do big breasts disadvantage women with breast cancer? Aust N Z J Surg 1989;59:115-17.
68. Ingram D, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D. Obesity and breast disease. The role of the female sex hormones. Cancer 1989;64:1049-53.
69. Schapira DV, Kumar NB, Lyman GH, Cox CE. Obesity and body fat distribution and breast cancer prognosis. Cancer 1991;67:523-8.
70. Daniell HW. Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 1988;62:429-35.
71. Newman SC, Lees AW, Jenkins HJ. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 1997;26:484-90.
72. Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 2005;1-10.
73. Honda H, Ohi Y, Umekita Y, Takasaki T, Kuriwaki K, Ohyabu I, et al. Obesity affects expression of progesterone receptors and node metastasis of mammary carcinomas in postmenopausal women without a family history. Pathol Int 1999;49:198-202.
74. Maehle BO, Tretli S, Thorsen T. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS 2004;112:349-57.
75. Barber GR, Miransky J, Brown AE, Coit DG, Lewis FM, Thaler HT, et al. Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 1995;130:1042-7.
76. Nieto A, Lozano M, Moro MT, Keller J, Carralafuente C. Determinants of wound infections after surgery for breast cancer. Zentralbl Gynakol 2002;124:429-33.
77. Vinton AL, Traverso LW, Jolly PC. Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg 1991;161:584-8.
78. Vilar-Compte D, Jacquemin B, Robles-Vidal C, Volkow P. Surgical site infections in breast surgery: case-control study. World J Surg 2004;28:242-6.
79. Derossis AM, Fey JV, Cody HS III, Borgen PI. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg 2003;197:896-901.
80. Meek AG. Breast radiotherapy and lymphedema. Cancer 1998;83(12 Suppl American):2788-97.
81. Kocak Z, Overgaard J. Risk factors of arm lymphedema in breast cancer patients. Acta Oncol 2000;39:389-92.
82. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J 2004;10:405-11.
83. Newman LA, Kuerer HM, McNeese MD, Hunt KK, Gurtner GC, Vlastos GS, et al. Reduction mammoplasty improves breast conservation therapy in patients with macromastia. Am J Surg 2001;181:215-20.
84. Madarnas Y, Sawka CA, Franssen E, Bjarnason GA. Are medical oncologists biased in their treatment of the large woman with breast cancer? Breast Cancer Res Treat 2001;66:123-33.
85. Griggs JJ, Sorbero ME, Lyman GH. Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 2005;165:1267-73.
86. Rosner GL, Hargis JB, Hollis DR, Budman DR, Weiss RB, Henderson IC, et al. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 1996;14:3000-8.
87. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW, Buzdar AU. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994;120:18-25.
88. Poikonen P, Blomqvist C, Joensuu H. Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area. Acta Oncol 2001;40:67-71.
89. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003;95:1467-76.
90. Schwartz AL. Exercise and weight gain in breast cancer patients receiving chemotherapy. Cancer Pract 2000;8:231-7.